379 results
Page 16 of 19
8-K
afod14elz
20 Dec 05
Discovery Labs Announces Completion of $20.0 Million Registered Direct Offering
12:00am
8-K
EX-99.1
nb3y5w4blub
14 Dec 05
Discovery Labs to Raise $20.0 Million in Registered Direct Offering
12:00am
8-K
EX-99.1
x3prn43r566l
12 Dec 05
Entry into a Material Definitive Agreement
12:00am
8-K
vbux07425zgskes6
12 Dec 05
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
52x60
3 Nov 05
Discovery Labs’ Reports Third Quarter 2005 Financial Results and Business Progress
12:00am
8-K
yghd 7igzuuet
27 Oct 05
Entry into a Material Definitive Agreement
12:00am
8-K
EX-99.1
djajggnu8 o8
21 Oct 05
FDA Accepts Discovery Labs’ Complete Response to
12:00am
8-K
0qmmor5g3odyvz7 ui
21 Oct 05
FDA Accepts Discovery Labs’ Complete Response to
12:00am
8-K
EX-99.1
jfvyef
12 Oct 05
Discovery Labs Files Universal Shelf Registration Statement
12:00am
8-K
etvk9w
12 Oct 05
Discovery Labs Files Universal Shelf Registration Statement
12:00am
8-K
EX-99.1
0tk7qs ucj
9 Sep 05
Discovery Labs Completes Pilot Phase 2 Study of Investigational Drug Aerosurf™, its Aerosolized Surfactant Delivered via Nasal CPAP
12:00am
8-K
z25frpmofrt qeevyx9f
9 Sep 05
Discovery Labs Completes Pilot Phase 2 Study of Investigational Drug Aerosurf™, its Aerosolized Surfactant Delivered via Nasal CPAP
12:00am
8-K
trdks86ghag2guqoip8g
19 Aug 05
Other Events
12:00am
8-K
EX-99.1
5hd3x5 9c
19 Aug 05
Other Events
12:00am
8-K
EX-99.1
psd5zie4zrai
3 Aug 05
Discovery Labs Reports Second Quarter 2005 Financial Results
12:00am
8-K
EX-99.1
kilwhaej8
1 Aug 05
Discovery Labs Submits Response to FDA Approvable Letter for SurfaxinÒ for RDS in Premature Infants
12:00am
8-K
2e1y6jczqdc841tc
1 Aug 05
Discovery Labs Submits Response to FDA Approvable Letter for SurfaxinÒ for RDS in Premature Infants
12:00am